Marketing In Brief

Stem Cell Assurance: "One of the first companies to provide adult stem cell collection and banking services to the general adult population," Boca Raton, Fla.-based Stem Cell Assurance introduces anti-aging skin care featuring Mibelle Biochemistry's PhytoCellTec Malus Domestica. According to Mibelle, the liposomal preparation features stem cells extracted from a rare, "ageless" Swiss apple (Uttwiler Spatlauber) and "has been shown to protect skin stem cells and delay the senescence of hair follicles." Stem Cell Assurance's Stem Cellutrition line consists of peptide-enhanced Plant Stem Cell Serum, which achieves the "miracle of creation [in] the birth of smooth, youthful skin," Glycolic Apple Cleanser for "maximizing the tissue's availability to the serum's benefits," and Apple Amber Scrub. The set of three products retails for $175. "With our vast physician network and scientists, we are proud to launch a scientifically based cosmetic formulation based on current research and cutting-edge technology using stem cells," says Director of Medical Alliances Robert Kast. New York company Emerge Labs also uses Mibelle's plant stem cell technology in its $120 Swiss Apple Stem Cell Serum (1"The Rose Sheet" Sept. 28, 2009). Grape stem cells Emerge: New sun-protection cream from Emerge Labs incorporates another Mibelle ingredient - PhytoCellTec Solar Vitis - based on stem cells derived from the Gamay Teinturier Freaux grape. Grape's free-radical-scavenging anthocyanins and other metabolites combat photo-aging by "protect[ing] and maintain[ing] the activity of epidermal stem cells, even in cases of stress induced by UV." Grape Solar Stem Cell Protection Cream with SPF 30 costs $90

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Archive

Non-US Approvals - Clone

Devices authorized for marketing outside the US. Data derived from Citeline’s Meddevicetracker. Updated weekly.

Patient access to unapproved medical products allowed under DeFazio, Daschle bills.

 
• By 

PATIENT ACCESS TO UNAPPROVED MEDICAL PRODUCTS WOULD BE ALLOWED under legislation introduced by Rep. Peter DeFazio (D-Ore.) on July 12 and Sen. Tom Daschle (D-S.D.) on July 14. Called the Access to Medical Treatment Act, the legislation would allow health practitioners to administer unapproved drugs, devices, foods or dietary supplements to patients as long as there is no evidence the treatment causes harm and the patient is informed about the treatment and its possible side effects. DeFazio's bill is identified as HR 2019; Daschle's version will be assigned a bill number the week of July 17.

ADHD Medications and Cardiovascular Effects: New Data Revealed. (A Comprehensive Evaluation of Emerging Clinical and Epidemiological Evidence on the Cardiovascular Effects Associated with Commonly Prescribed Medications for Attention Deficit Hyperactivity Disorder)

 
• By 

A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.

More from HBW Insight

data

Type:DataArticle | Publication:HBW | Section:Health | Paywall:Premium — Article containing all Composer content for testing (Do not update)

 
• By 

To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.

Test: PDF Link Lifetime

Description description

headline test

description